ENTA’s EDP-305 for NASH gets FDA Fast Track designation: http://finance.yahoo.com/news/fda-grants-fast-track-designation-123000438.html Fast Track (as opposed to BTD) means essentially nothing; however, this announcement may open some eyes to the fact that ENTA is not just a HCV company, but rather has a potentially valuable NASH program. See #msg-125454754 for related info.